Xeroderma pigmentosum variant cells are resistant to immortalization

Area of Science:

• Genetics
• Molecular Biology
• Cell Biology

Background:

• Xeroderma pigmentosum (XP) is a rare human DNA repair disorder.
• Mutations in eight genes cause XP; however, the gene for the XP variant (XPV) remains un-cloned.
• Difficulty in creating stable cell lines impedes XPV research.

Purpose of the Study:

• To immortalize fibroblasts from XPV patients to facilitate gene cloning.
• To characterize the XPV disease and identify the causative gene.

Main Methods:

• Utilized multiple cell immortalization techniques, including transfection with SV40 large T antigen, X-ray irradiation, and human papillomavirus-16.
• Attempted immortalization of XPV fibroblasts using various combinations of genetic modification and chemical treatments.
• Screened a large number of cells (up to 2 x 10^8) for successful immortalization.

Main Results:

• Successfully immortalized only one XPV cell line (XP30RO) out of numerous attempts.
• Established immortal cell lines from Cockayne syndrome A and B patients, but not from XPV patients, highlighting the unique challenges with XPV.
• Demonstrated the difficulty in establishing immortalized XPV cell lines compared to other XP complementation groups.

Conclusions:

• The biochemical defect in XPV cell lines, related to replicating damaged DNA, may involve a replication factor interacting with SV40 T antigen.
• The absence of this factor might explain the difficulties encountered in immortalizing XPV cell lines.
• Further research is needed to clone the XPV gene and understand its role in DNA replication and repair.